WCN26-7070 EFFECTIVENESS OF HYDROXYCHLOROQUINE IN NON-CHINESE PATIENTS WITH IGA NEPHROPATHY

Read full text Summarise with VIRAT
Authors: Jenny Koo Ng, Brandi Grozell, Kevin Yau, Michelle Hladunewich
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Hydroxychloroquine (HCQ) has been reported to be effective in lowering urinary protein in Chinese patients with IgA nephropathy (IgAN).1 2 In a randomized placebo controlled trial by Li et al. evaluating HCQ versus placebo in Asian patients with proteinuria of 0.75–3.5 g/d despite optimized renin-angiotensin-aldosterone system (RAAS) inhibitor therapy, proteinuria was reduced by 48% vs 10% in the placebo group at 6 months.3 However, there has been limited reports of the effectiveness of HCQ in other patient populations.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Chronic Kidney Disease and Diabetes Vasculitis and related conditions

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
106286–106286
Publication date
25 March 2026
Language
EN